Current management and prognosis of patients with recurrent myocardial infarction

Recurrent myocardial infarction (re-MI) is a common event following acute coronary syndrome (ACS), especially during the first year. According to epidemiological studies, patients who experience reMI are at higher risk of all-cause cardiovascular events and mortality. The cornerstones of re-MI prevention include complete functional coronary revascularization, effective dual antiplatelet therapy and secondary prevention strategies. Notwithstanding this, some controversy still exists on the definition and management of re-MI, and no dedicated studies have been designed or conducted so far in this setting. We here provide an overview of epidemiological and prognostic data on ACS patients experiencing re-MI, along with current available treatment and preventive options.

Automated summary

Recurrent myocardial infarction is a common occurrence following acute coronary syndrome, particularly in the first year, with patients at higher risk of cardiovascular events and mortality. Prevention strategies include complete coronary revascularization, effective dual antiplatelet therapy, and secondary prevention measures, although there is ongoing controversy and lack of dedicated studies on the management of re-MI.